OsseoGuard membranes are specifically engineered to eliminate bacterial infiltration into the surgical site while preventing tissue from growing into the bone cavity. High-density PTFE used in the manufacturing process greatly reduces the membrane’s pore size to a submicron (less than 0.3 microns) level. OsseoGuard non-resorbable dental membranes are recommended in certain complex cases, such as vertical ridge augmentation procedures, where longer lasting and space-maintaining membranes are needed because resorbable products may resorb too quickly.
“Zimmer Biomet Dental is very excited to now provide advanced barrier membranes and sutures to our customers for ridge augmentation and other relevant procedures,” said Indraneel Kanaglekar, Vice President, Global Product Management and R&D. “As a market leader in dental regenerative solutions, it is important that we keep diversifying and growing our available solutions in order to address the specific needs and preferences of clinicians.”
OsseoGuard non-resorbable membranes are available in a variety of textured, smooth (non-textured), titanium reinforced and titanium mesh options, giving a clinician the choice of different handling, shapes, sizes and thicknesses. OsseoGuard sutures offer eight precision needle options. These new products supplement the already robust portfolio of resorbable membranes, which includes Puros® Pericardium, CopiOs® Pericardium, CopiOs Extend®, BioMend®, BioMend Extend™, OsseoGuard and OsseoGuard Flex®.
For more information on OsseoGuard Non-Resorbable Membranes and Sutures, or any of Zimmer Biomet Dental’s solutions for regenerative procedures, contact a Zimmer Biomet sales representative or visit www.zimmerbiometdental.com.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking Statements
This release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. Forward-looking statements speak only as of the date made. Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this release.
